• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
HLS
Click for more information
16.0% $1.34

HEALIUS LIMITED - Announcements

Market Cap $1.212B  ! watchlist Created with Sketch. Add to my watchlist

Healius Limited is a healthcare company. The Company’s segments include Pathology,... Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
HLS 2024 Annual General Meeting Information19/09/24
HLS 2024 Healius Corporate Governance Statement19/09/24
HLS Appendix 4G19/09/24
HLS 2024 Healius Annual Report19/09/24
HLS Change in substantial holding25/02/19
HLS Presentation of Half Year ResultsPRICE SENSITIVE15/02/19
HLS Healius Announces Half Year 2019 ResultPRICE SENSITIVE15/02/19
HLS Dividend/Distribution - HLS15/02/19
HLS Half Yearly Report and AccountsPRICE SENSITIVE15/02/19
HLS Ceasing to be a substantial holder31/01/19
HLS Proposed issue of securities29/01/19
HLS Rejection of Non-Binding Indication of InterestPRICE SENSITIVE07/01/19
HLS Non-binding indicative proposal for acquisition of HealiusPRICE SENSITIVE03/01/19
HLS Change in substantial holding24/12/18
HLS Appendix 3Y Change of Director's Interest Notice21/12/18
HLS Proposed issue of securities17/12/18
HLS Change of ASX code to HLS05/12/18
HLS Change of Company name to Healius Limited03/12/18
HLS Appendix 3Y Change of Director's Interest Notice28/11/18
HLS Becoming a substantial holder22/11/18
HLS Results of Meeting22/11/18
HLS AGM PresentationPRICE SENSITIVE22/11/18
HLS MD & CEO's address to ShareholdersPRICE SENSITIVE22/11/18
HLS Return on Invested Capital - targets for FY 2019 LTI Plan09/11/18
HLS Ceasing to be a substantial holder from MAB01/11/18
HLS Becoming a substantial holder from NAB30/10/18
HLS Payments under modern awards26/10/18
HLS Appendix 3B24/10/18
HLS Change in substantial holding22/10/18
HLS Notice of Annual General Meeting/Proxy Form19/10/18
HLS Proposed issue of securities15/10/18
HLS Appendix 3Y Change of Director's Interest Notice15/10/18
HLS Change in substantial holding05/10/18
HLS Appendix 4G28/09/18
HLS Corporate Governance Statement 201828/09/18
HLS 2018 Annual Report28/09/18
HLS Proposed issue of securities19/09/18
HLS Appendix 3Y Change of Director's Interest Notice18/09/18
HLS Appendix 3Y Change of Director's Interest Notice18/09/18
HLS Appendix 3Y Change of Director's Interest Notice18/09/18
HLS Appendix 3Y Change of Director's Interest Notice18/09/18
HLS Appendix 3Y Change of Director's Interest Notice18/09/18
HLS Appendix 3Y Change of Director's Interest Notice18/09/18
HLS Change in substantial holding17/09/18
HLS Dorevitch Pathology - Fair Work Commission determinationPRICE SENSITIVE14/09/18
HLS Appendix 3B14/09/18
HLS Primary successfully completes Retail Entitlement Offer12/09/18
HLS Acquisition of Montserrat Day HospitalsPRICE SENSITIVE10/09/18
HLS Appendix 3Y Change of Director's Interest Notice05/09/18
HLS Appendix 3Y Change of Director's Interest Notice04/09/18
HLS Change in substantial holding31/08/18
HLS Change in substantial holding31/08/18
HLS Ceasing to be a substantial holder30/08/18
HLS Appendix 3B28/08/18
HLS Copy of Notification to Ineligible Retail Shareholders27/08/18
HLS Retail Offer Booklet and Acceptance Form27/08/18
HLS Change in substantial holding27/08/18
HLS PRY successfully completes Institutional Entitlement OfferPRICE SENSITIVE22/08/18
HLS Initial Director's Interest Notice21/08/18
HLS Cleansing notice - Section 708AA20/08/18
HLS Appendix 3B20/08/18
HLS Investor presentation- growth initiatives and capital raisePRICE SENSITIVE20/08/18
HLS Strategic Growth - Non-Renounceable Entitlement OfferPRICE SENSITIVE20/08/18
HLS FY 2018 Results PresentationPRICE SENSITIVE20/08/18
HLS Press Release FY 2018 ResultsPRICE SENSITIVE20/08/18
HLS Dividend/Distribution - PRY20/08/18
HLS Appendix 4E Preliminary Final ReportPRICE SENSITIVE20/08/18
HLS ASX Market Release - Trading HaltPRICE SENSITIVE20/08/18
HLS Response to media speculationPRICE SENSITIVE13/08/18
HLS Final Director's Interest Notice24/07/18
HLS Board Changes24/07/18
HLS Appendix 3B13/07/18
HLS Ceasing to be a substantial holder08/06/18
HLS Change in substantial holding25/05/18
HLS Becoming a substantial holder23/04/18
HLS Change in substantial holding13/04/18
HLS Change in substantial holding16/03/18
HLS Change in substantial holding08/03/18
HLS Ceasing to be a substantial holder27/02/18
HLS Change in substantial holding27/02/18
HLS Ceasing to be a substantial holder21/02/18
HLS Appendix 3Y Change of Director's Interest Notice20/02/18
HLS Ceasing to be a substantial holder20/02/18
HLS Change in substantial holding16/02/18
HLS Presentation of Half Year Results16/02/18
HLS Primary announces growth in profit and free cash flow16/02/18
HLS Dividend/Distribution - PRY16/02/18
HLS Half Yearly Report and AccountsPRICE SENSITIVE16/02/18
HLS Appendix 3B15/02/18
HLS Change in substantial holding06/02/18
HLS Becoming a substantial holder29/01/18
HLS Appendix 3Y Change of Director's Interest Notice03/01/18
HLS Ceasing to be a substantial holder27/12/17
HLS Primary acquires Brisbane Private ImagingPRICE SENSITIVE20/12/17
HLS Syndicated Bank Debt Refinancing20/12/17
HLS Becoming a substantial holder15/12/17
HLS Ceasing to be a substantial holder12/12/17
HLS Retracting Notification: Ceasing to be a substantial holder07/12/17
HLS Ceasing to be a substantial holder06/12/17
HLS Becoming a substantial holder05/12/17
HLS 2024 Annual General Meeting Information
19/09/24
HLS 2024 Healius Corporate Governance Statement
19/09/24
HLS Appendix 4G
19/09/24
HLS 2024 Healius Annual Report
19/09/24
HLS Change in substantial holding
25/02/19
HLS Presentation of Half Year Results
15/02/19PRICE SENSITIVE
HLS Healius Announces Half Year 2019 Result
15/02/19PRICE SENSITIVE
HLS Dividend/Distribution - HLS
15/02/19
HLS Half Yearly Report and Accounts
15/02/19PRICE SENSITIVE
HLS Ceasing to be a substantial holder
31/01/19
HLS Proposed issue of securities
29/01/19
HLS Rejection of Non-Binding Indication of Interest
07/01/19PRICE SENSITIVE
HLS Non-binding indicative proposal for acquisition of Healius
03/01/19PRICE SENSITIVE
HLS Change in substantial holding
24/12/18
HLS Appendix 3Y Change of Director's Interest Notice
21/12/18
HLS Proposed issue of securities
17/12/18
HLS Change of ASX code to HLS
05/12/18
HLS Change of Company name to Healius Limited
03/12/18
HLS Appendix 3Y Change of Director's Interest Notice
28/11/18
HLS Becoming a substantial holder
22/11/18
HLS Results of Meeting
22/11/18
HLS AGM Presentation
22/11/18PRICE SENSITIVE
HLS MD & CEO's address to Shareholders
22/11/18PRICE SENSITIVE
HLS Return on Invested Capital - targets for FY 2019 LTI Plan
09/11/18
HLS Ceasing to be a substantial holder from MAB
01/11/18
HLS Becoming a substantial holder from NAB
30/10/18
HLS Payments under modern awards
26/10/18
HLS Appendix 3B
24/10/18
HLS Change in substantial holding
22/10/18
HLS Notice of Annual General Meeting/Proxy Form
19/10/18
HLS Proposed issue of securities
15/10/18
HLS Appendix 3Y Change of Director's Interest Notice
15/10/18
HLS Change in substantial holding
05/10/18
HLS Appendix 4G
28/09/18
HLS Corporate Governance Statement 2018
28/09/18
HLS 2018 Annual Report
28/09/18
HLS Proposed issue of securities
19/09/18
HLS Appendix 3Y Change of Director's Interest Notice
18/09/18
HLS Appendix 3Y Change of Director's Interest Notice
18/09/18
HLS Appendix 3Y Change of Director's Interest Notice
18/09/18
HLS Appendix 3Y Change of Director's Interest Notice
18/09/18
HLS Appendix 3Y Change of Director's Interest Notice
18/09/18
HLS Appendix 3Y Change of Director's Interest Notice
18/09/18
HLS Change in substantial holding
17/09/18
HLS Dorevitch Pathology - Fair Work Commission determination
14/09/18PRICE SENSITIVE
HLS Appendix 3B
14/09/18
HLS Primary successfully completes Retail Entitlement Offer
12/09/18
HLS Acquisition of Montserrat Day Hospitals
10/09/18PRICE SENSITIVE
HLS Appendix 3Y Change of Director's Interest Notice
05/09/18
HLS Appendix 3Y Change of Director's Interest Notice
04/09/18
HLS Change in substantial holding
31/08/18
HLS Change in substantial holding
31/08/18
HLS Ceasing to be a substantial holder
30/08/18
HLS Appendix 3B
28/08/18
HLS Copy of Notification to Ineligible Retail Shareholders
27/08/18
HLS Retail Offer Booklet and Acceptance Form
27/08/18
HLS Change in substantial holding
27/08/18
HLS PRY successfully completes Institutional Entitlement Offer
22/08/18PRICE SENSITIVE
HLS Initial Director's Interest Notice
21/08/18
HLS Cleansing notice - Section 708AA
20/08/18
HLS Appendix 3B
20/08/18
HLS Investor presentation- growth initiatives and capital raise
20/08/18PRICE SENSITIVE
HLS Strategic Growth - Non-Renounceable Entitlement Offer
20/08/18PRICE SENSITIVE
HLS FY 2018 Results Presentation
20/08/18PRICE SENSITIVE
HLS Press Release FY 2018 Results
20/08/18PRICE SENSITIVE
HLS Dividend/Distribution - PRY
20/08/18
HLS Appendix 4E Preliminary Final Report
20/08/18PRICE SENSITIVE
HLS ASX Market Release - Trading Halt
20/08/18PRICE SENSITIVE
HLS Response to media speculation
13/08/18PRICE SENSITIVE
HLS Final Director's Interest Notice
24/07/18
HLS Board Changes
24/07/18
HLS Appendix 3B
13/07/18
HLS Ceasing to be a substantial holder
08/06/18
HLS Change in substantial holding
25/05/18
HLS Becoming a substantial holder
23/04/18
HLS Change in substantial holding
13/04/18
HLS Change in substantial holding
16/03/18
HLS Change in substantial holding
08/03/18
HLS Ceasing to be a substantial holder
27/02/18
HLS Change in substantial holding
27/02/18
HLS Ceasing to be a substantial holder
21/02/18
HLS Appendix 3Y Change of Director's Interest Notice
20/02/18
HLS Ceasing to be a substantial holder
20/02/18
HLS Change in substantial holding
16/02/18
HLS Presentation of Half Year Results
16/02/18
HLS Primary announces growth in profit and free cash flow
16/02/18
HLS Dividend/Distribution - PRY
16/02/18
HLS Half Yearly Report and Accounts
16/02/18PRICE SENSITIVE
HLS Appendix 3B
15/02/18
HLS Change in substantial holding
06/02/18
HLS Becoming a substantial holder
29/01/18
HLS Appendix 3Y Change of Director's Interest Notice
03/01/18
HLS Ceasing to be a substantial holder
27/12/17
HLS Primary acquires Brisbane Private Imaging
20/12/17PRICE SENSITIVE
HLS Syndicated Bank Debt Refinancing
20/12/17
HLS Becoming a substantial holder
15/12/17
HLS Ceasing to be a substantial holder
12/12/17
HLS Retracting Notification: Ceasing to be a substantial holder
07/12/17
HLS Ceasing to be a substantial holder
06/12/17
HLS Becoming a substantial holder
05/12/17
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$1.34 		Change
-0.255(16.0%) 		Mkt cap ! $1.212B
Open High Low Value Volume
$1.61 $1.61 $1.30 $16.38M 12.00M

Buyers (Bids)

No. Vol. Price($)
1 7500 $1.33
 

Sellers (Offers)

Price($) Vol. No.
$1.34 40115 3
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
Last
$1.33 		  Change
-0.255 ( 15.8 %)
Open High Low Volume
$1.61 $1.61 $1.30 7277045
Last updated 15.59pm 15/11/2024 ?
HLS (ASX) Chart

Top Stories

Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing

Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Cyclone signs MOU with Vale for development of Iron Bear play Cyclone Metals Lt has signed a Memorandum of Understanding with Vale S.A to support development of the former's iron ore project in Canada
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.